← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2005Last known activity
Oct 13, 2020
Timeline
1990s
- Jun 1, 1999
Candel Therapeutics— Founded
Drugs by trial phase (11 distinct, 11 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT04495153Lead sponsorPhase 2Oct 13, 2020
- NCT03576612CollaboratorPhase 1Feb 27, 2018
- NCT03131037Lead sponsorPhase 1May 1, 2017
- NCT02768363Lead sponsorPhase 2/Phase 3May 1, 2016
- NCT02446093Lead sponsorPhase 1/Phase 2Oct 1, 2015
- NCT01997190Lead sponsorPhase 1Oct 1, 2013
- NCT01436968Lead sponsorPhase 3Sep 1, 2011
- NCT00634231Lead sponsorPhase 1Apr 1, 2010
- NCT00638612Lead sponsorPhase 1Aug 1, 2008
- NCT00589875Lead sponsorPhase 2Mar 1, 2007
- NCT00751270Lead sponsorPhase 1Nov 1, 2005
Details
- Founded
- Auburndale, MA, US Jun 1, 1999
- Last known activity
- Oct 13, 2020
Notes
Formerly known as Advantagene, Inc.